Like KMR Group

closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired KMR Group

synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired KMR Group, a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: KMR Group
KMR Group is a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry. KMR offers leading-edge data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2014 via Company Press Release

Cello Group, acquired Promedica, Inc

synopsis: Cello Group plc, the healthcare and consumer strategic marketing group, is pleased to announce the acquisition of Worldwide Promedica Inc. Promedica is a San Francisco based market research firm serving pharmaceutical and biotechnology companies.
buyer: Cello Group (CLLL:$204.91)
Cello is a leading global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors in addition to deep expertise in a range of other high margin sectors. "
target: Promedica, Inc
Promedica’s mission is to provide primary marketing research in the area of new product planning with an exclusive focus on healthcare, and a client-side perspective. Their ultimate goal is to optimize client's marketing research investment and contribute to company’s success.
price ($mm)
$0.70
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.3x
EV / EBITDA
closed 11/1/2018 via Company Press Release

BioInformatics Inc., acquired Kalorama Information

synopsis: BioInformatics Inc., the premier research and advisory company serving the life science industry, has acquired Kalorama Information from MarketResearch. Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics, imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target parent: MarketResearch.com, Inc.
target: Kalorama Information
Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals. Kalorama only publishes in healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2014 via Company Press Release

BioPharm Communications, LLC, acquired Carson Analytics

synopsis: BioPharm Communications, a portfolio company of Southfield Capital and minority shareholder Boathouse Capital has announced the acquisition of Carson Analytics. Carson Analytics is a leading provider of integrated commercial analytics solutions for the pharmaceutical and biotechnology industries.
buyer parent: Southfield Capital Advisors
buyer: BioPharm Communications, LLC
BioPharm develops promotional medical education programs for customers in the pharmaceutical and biotechnology industries. The company creates robust clinical content in collaboration with key opinion leaders and delivers it to healthcare practitioners through the company's comprehensive suite. "
target: Carson Analytics
Carson Analytics is a leading provider of integrated commercial analytics solutions for the pharmaceutical and biotechnology industries. They provide advanced analytics solutions including forecasting, promotion response analysis and optimization of promotion mix.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2020 via BNC Analysis

Integrated Medhealth Communication, acquired Porterhouse Medical Group

synopsis: Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity. Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.
buyer parent: Waterland Private Equity Investments
buyer: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world. "
target: Porterhouse Medical Group
Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry, with a focus on activities that have a beneficial and measurable impact on healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/31/2009 via BusinessWire

URCH Publishing, Ltd., acquired Spectra Intelligence

synopsis: URCH Publishing Ltd, a well-respected and established publisher of quality market intelligence reports covering the global pharmaceutical and healthcare industry, acquired Spectra Intelligence, a privately owned publisher of specialised and syndicated pharmaceutical market research.
buyer: URCH Publishing, Ltd.
URCH Publishing Ltd is an independent business information publisher dedicated to delivering quality information products to the global pharmaceuticals industry. The company is based in London, UK. "
target: Spectra Intelligence
Spectra Intelligence was founded in 2005 to provide syndicated market research information to the global life sciences industry and capital investment sector.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2007 via

Decision Resources, Inc., purchased Life Sciences business from Wood Mackenzie

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced that it plans to acquire Wood Mackenzie's Life Sciences business.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
seller: Wood Mackenzie
Wood Mackenzie has been providing its unique range of consulting services and research products to the Energy and Life Sciences industries for over 30 years. Our market proposition is based on our ability to provide forward- looking insight that enables our clients to make better business decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired KMR Group

synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired KMR Group, a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: KMR Group
KMR Group is a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry. KMR offers leading-edge data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2019 via PR Newswire

The WIRB-Copernicus Group, acquired Waife & Associates, Inc.

synopsis: WIRB-Copernicus Group (WCG) has acquired Waife & Associates, Inc. (W&A), a provider of management consulting services for biopharmaceutical clinical research clients. W&A focuses on making clinical development more efficient and productive through improvements in organization, process, and technology.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WCG (WIRB-Copernicus Group) is the world's leading provider of solutions that improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, clinical research organizations, and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: Waife & Associates, Inc.
Waife & Associates (W&A) provides the clinical research industry with management and operational consulting delivered with senior domain expertise. W&A designs cost-effective solutions for clinical operations and data management, and all related functions and software technologies involved.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/30/2019 via Company Press Release

The WIRB-Copernicus Group, acquired First Clinical Research LLC

synopsis: The WIRB-Copernicus Group®’s (WCG™) Market Intelligence & Insights Division has acquired First Clinical Research LLC, organizer of the MAGI (Model Agreements & Guidelines International) Clinical Research Conference. First Clinical also publishes the Journal of Clinical Research Best Practices.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG enables institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining high safety standards. "
target: First Clinical Research LLC
First Clinical Research LLC is the organizer of the MAGI (Model Agreements & Guidelines International) Clinical Research Conference, which unifies the clinical research ecosystem by facilitating communication and the sharing of best practices among members.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired KMR Group

synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired KMR Group, a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: KMR Group
KMR Group is a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry. KMR offers leading-edge data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired Metrics Champion Consortium

synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired Metrics Champion Consortium (MCC), an association dedicated to the development of standardized performance metrics to improve clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: Metrics Champion Consortium
Metrics Champion Consortium (MCC) is an association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers, and sites to improve clinical trial development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/27/2018 via Company Press Release

The WIRB-Copernicus Group, acquired ACI Clinical

synopsis: WIRB-Copernicus Group, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired ACI Clinical, a specialty provider of clinical trial committees and clinical trial advisory services.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ACI Clinical
ACI Clinical is a specialty provider of clinical trial committees and clinical trial advisory services. ACI Clinical specializes in clinical and safety consulting, including full service Endpoint Adjudication Committees and Data Monitoring Committees.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2017 via PR Newswire

The WIRB-Copernicus Group, purchased ConsentNow from Patient Genesis

synopsis: WIRB-Copernicus Group announced that it has acquired Patient Genesis' ConsentNow™ eConsent technology. ConsentNow is a web and mobile-based technology platform that allows pharmaceutical, healthcare, or medical device makers to disclose critical information in an easy-to-use, patient-friendly format.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
seller: Patient Genesis
The acquisition includes the ConsentNow™ eConsent technology from Patient Genesis. ConsentNow is a web and mobile-based technology platform that allows pharmaceutical, healthcare, or medical device makers to disclose critical information in an easy-to-use, patient-friendly format.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2017 via PR Newswire

The WIRB-Copernicus Group, acquired MedAvante, Inc.

synopsis: WIRB-Copernicus Group® (WCG™), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced that it has acquired MedAvante. MedAvante is a clinical science-driven data services company dedicated to maximizing signal detection in global clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: MedAvante, Inc.
MedAvante is a clinical science-driven data services company dedicated to maximizing signal detection in clinical trials. With Virgil™, its electronic clinical outcome assessment (eCOA) platform, clinical research sponsors are able to maximize outcome data quality & increase operational efficiency.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2017 via PR Newswire

The WIRB-Copernicus Group, acquired ProPhase, LLC

synopsis: WIRB-Copernicus Group® (WCG™), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced that it has acquired ProPhase. ProPhase is a global provider of measurement-related specialty solutions in clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ProPhase, LLC
ProPhase is a global provider of measurement-related specialty solutions in clinical trials. For over a decade, ProPhase has focused on applying innovation to optimize the selection, use, and analysis of behavioral endpoints to mitigate trial risk and maximize the likelihood of study success.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/2/2017 via PR Newswire

The WIRB-Copernicus Group, acquired ThreeWire, Inc.

synopsis: WIRB-Copernicus Group, the leading provider of solutions that improve the quality & efficiency of clinical research, has acquired ThreeWire, the patient recruitment, enrollment, & retention firm that uses a systematic approach to help biopharmaceutical, medical device companies & clinical research organizations achieve their clinical trial goals.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ThreeWire, Inc.
ThreeWire is the global patient recruitment, enrollment, and retention firm that uses a systematic, patient-focused approach to help biopharmaceutical and medical device companies and clinical research organizations achieve their clinical trial enrollment and retention goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/22/2016 via PR Newswire

The WIRB-Copernicus Group, acquired CenterWatch, Inc.

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information. CenterWatch provides clinical trials information to clinical research professionals.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
target: CenterWatch, Inc.
CenterWatch is the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs, to investigative sites, technology solutions and niche providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/15/2016 via PR Newswire

The WIRB-Copernicus Group, will purchase Clinical Trial Applications from karmadata

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality of clinical research, will acquire from karmadata a suite of proprietary applications designed to facilitate the management of clinical trial data. karmadata is the market leader in clinical trial database and decision support applications.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
seller: karmadata
Karmadata is able to standardize and link the world's healthcare data ranging from leading open data sources to priva pharmacy and medical claims. Its propriety applications are designed to facilitate the management of clinical trial data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via PR Newswire

The WIRB-Copernicus Group, acquired ePharmaSolutions, Inc.

synopsis: WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced that ePharmaSolutions (ePS) has joined its group of companies. ePharmaSolutions is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical solutions for clinical research, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) review. "
target: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2013 via PR Newswire

The WIRB-Copernicus Group, acquired IRBNet

synopsis: Arsenal Capital Partners, a private equity firm that invests in middle market healthcare and specialty industrial companies, announced the acquisition by its portfolio company, The WIRB-Copernicus Group, of Research Dataware, LLC, software developer and provider of IRBNet, the leading software application supporting institutional review boards.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
With more than 60 years of combined experience reviewing research protocols and study-related information, it is the mission of The WIRB-Copernicus Group to meet the highest standards of ethics and science, and to ensure the safety and welfare of subjects worldwide. "
target: IRBNet
IRBNet offers the world's leading and most widely used electronic solution for managing research compliance for institutions of any size, with more than 1,600 large, medium and small research institutions, boards and research sites registered on the National Research Network®.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2015 via PR Newswire

Schulman Associates Institutional Review Board, acquired Absolute Research

synopsis: Schulman Associates IRB, Inc., a customer service and technology company, has acquired Absolute Research. Absolute Research provides protection for human subjects involved in research while supporting a research enterprise. Absolute Research allows research administrators to navigate obstacles for biomedical and social-behavioral research.
buyer: Schulman Associates Institutional Review Board
Schulman Associates IRB is a leader in the protection of human research participants that offers IRB review services to clinical trial sponsors, CROs, and institutions. Schulman offers consulting services that improve clinical studies, data integrity and the protection of human subjects. "
target: Absolute Research
AbsoluteResearch accesses information to advise investigators on regulatory issues and make decisions for an IRB office. Their tools use experiences in IRB Management as well as Bioethics and with their Web-Based Solution they enable Research Institutes to analyze guidance from regulatory agencies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/14/2017 via Company Press Release

Cressey & Co., Spectrum Equity, acquired Verisys Corporation

synopsis: Verisys Corporation, a leading provider of technology solutions and primary-source data on healthcare professionals and businesses, announced that Spectrum Equity, along with Cressey & Company and Verisys CEO John P. Benson, have made a significant growth equity investment in the Company.
buyer: Spectrum Equity
buyer: Cressey & Co.
Spectrum Equity is a leading growth equity firm providing capital and strategic support to innovative Internet, software and information services companies. Cressey & Company LP is a private investment firm focused exclusively on investing in and building leading healthcare businesses. "
target: Verisys Corporation
Verisys is the leading provider of health care credentialing services with the most current, accurate, and comprehensive data and technology tools. Since 1992, Verisys has been leading the health care industry by providing the highest quality data coupled with deep health care industry experience.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/5/2015 via BusinessWire

LexisNexis Risk Solutions, acquired Health Market Science, Inc.

synopsis: LexisNexis® Risk Solutions, a division of Reed Elsevier, announced it has acquired Health Market Science (HMS), a leading supplier of high-quality data on health care professionals and an administrator of one of the largest practitioner-level medical claims databases in the U.S.
buyer parent: Reed Elsevier
buyer: LexisNexis Risk Solutions
LexisNexis Risk Solutions is a leader in providing essential information that helps customers across industries and government predict, assess and manage risk. They are a leading supplier of data and data management solutions for the health care industry. "
target parent: Edison Partners
target: Health Market Science, Inc.
Health Market Science (HMS), helps businesses and government entities solve complex business challenges centered on healthcare provider information. HMS develops agile solutions so their clients can improve compliance, reduce operational costs and maximize market opportunities in real time.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/1/2010 via PR Newswire

Thomson Reuters, acquired Healthcare Data Management, Inc.

synopsis: Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced that it has acquired Healthcare Data Management, Inc. Effective immediately, the company will become part of the Healthcare & Science business of Thomson Reuters.
buyer: Thomson Reuters (TRI:$5,921.00)
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. Powered by the world's most trusted news organization, Thomson Reuters combine industry expertise with innovative technology to deliver critical information to leading decision makers. "
target: Healthcare Data Management, Inc.
Healthcare Data Management was a pioneer in the establishment of modeling employee health benefit plans and using data-driven metrics to monitor plan performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like KMR Group


read more

KMR Group

Promedica, Inc

Kalorama Information

Carson Analytics

Porterhouse Medical Group

Spectra Intelligence

Wood Mackenzie

read more

KMR Group

read more

Waife & Associates, Inc.

First Clinical Research LLC

KMR Group

Metrics Champion Consortium

ACI Clinical

Patient Genesis

MedAvante, Inc.

ProPhase, LLC

ThreeWire, Inc.

CenterWatch, Inc.

karmadata

ePharmaSolutions, Inc.

IRBNet

read more

Absolute Research

Verisys Corporation

Health Market Science, Inc.

Healthcare Data Management, Inc.

Geography
Matching Companies